- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (748)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5047)
All Articles published online
|
Publishing Process of This Article
|
Jun 9, 2023 (publication date) through Dec 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Pediatrics
ISSN
2219-2808
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bitar R, Elghoudi AA, Rawat D, Azaz A, Miqdady M, Narchi H. COVID-19-induced liver injury in infants, children, and adolescents. World J Clin Pediatr 2023; 12(3): 57-67 [PMID: 37342451 DOI: 10.5409/wjcp.v12.i3.57] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2808/full/v12/i3/57.htm |
| Number | Citing Articles |
| 1 |
O. A. Pushkarenko, O. M. Horlenko, S. V. Feysa, A. I. Tomey. COMORBID PATIENT WITH ACTIVE SARS-CoV-2 INFECTION AND METABOLICASSOCIATED STEATOTIC LIVER DISEASE. Bulletin of Problems Biology and Medicine 2024; 1(1): 137 doi: 10.29254/2077-4214-2024-2-173-137-144
|
| 2 |
Samar A. Antar, Nada A. Ashour, Amir O. Hamouda, Ayman M. Noreddin, Ahmed A. Al‐Karmalawy. Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management. Inflammopharmacology 2024; 32(5): 2649 doi: 10.1007/s10787-024-01535-7
|
| 3 |
Tsuyoshi Jinda, Shinsuke Mizuno, Shunsuke Tatami, Masashi Kasai, Tatsuhiko Ishida. Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID‐19. Journal of Paediatrics and Child Health 2024; 60(7): 299 doi: 10.1111/jpc.16569
|
| 4 |
Brittany Player, Anna R. Huppler, Amy Y. Pan, Melodee Liegl, Peter L. Havens, Katie Ray, Michelle Mitchell, Kelly Graff. Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-09833-9
|
| 5 |
Mirela Luminița Pavelescu, Alexandru Dinulescu, Alexandru-Sorin Păsărică, Irina Dijmărescu, Daniela Păcurar. Hematological profile, inflammatory markers and serum liver enzymes in COVID 19 positive children vs. COVID 19 negative ones—a comparative study. Frontiers in Pediatrics 2024; 12 doi: 10.3389/fped.2024.1334591
|
| 6 |
Thomas Kalfas, Aris Kaltsas, Evangelos Symeonidis, Asterios Symeonidis, Athanasios Zikopoulos, Efthalia Moustakli, Chara Tsiampali, Georgios Tsampoukas, Natalia Palapela, Athanasios Zachariou, Nikolaos Sofikitis, Fotios Dimitriadis. COVID-19 and Male Infertility: Is There a Role for Antioxidants?. Antioxidants 2023; 12(8): 1483 doi: 10.3390/antiox12081483
|